Greenwhich Pharmaceuticals Inc & lt ; GRPI.O > said completed private placement common stock , generating eight mln dlrs net proceeds .
These fund , together two mln dlrs cash currently held company , used complete Therafectin rheumatoid arthritis drug development program develop drug , company said .
Reuter & # 3 ; 